NCT03874299已完成不适用
The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients-RNA-seq Signature Validation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 302
- 试验地点
- 1
- 主要终点
- To validate the use of a RNA-seq based peripheral blood assay in renal transplant recipients.
研究概览
简要总结
The researchers are trying to develop a way to measure the risk of rejection through the validation of a blood test.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult (>/=18 years) renal transplant recipient.
- •Patients who have given informed consent and are willing to comply with the protocol, including the use of their peripheral blood specimens and data for subsequent research.
排除标准
- •Adult (<18 years) renal transplant recipient.
结局指标
主要结局
To validate the use of a RNA-seq based peripheral blood assay in renal transplant recipients.
时间窗: 3 years
The study will validate the ability of a peripheral blood assay to assess the risk of biopsy proven rejection.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The TOGETHER Project - HeartHeart Transplant RejectionNCT03833050Mayo Clinic101
已完成
不适用
The TOGETHER Project - KidneyKidney Transplant RejectionNCT03873623Mayo Clinic250
已完成
不适用
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA DetectionTransplant RejectionAllograft RejectionComplicationsNCT03984747Natera, Inc.110
终止
2 期
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsAcute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaHodgkin LymphomaNCT03615105Memorial Sloan Kettering Cancer Center9
已完成
1 期
Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet ActionHealthy VolunteersNCT02060396Aragon Institute of Health Sciences24